Insilico Medicine is an AI-driven drug discovery company that uses generative AI to design novel drug molecules, identify disease targets, and predict clinical trial outcomes, with a pipeline spanning oncology, fibrosis, and immunology. It has demonstrated industry-leading speed in generating clinical candidates from concept to IND.